Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

A Promising Way To Reverse Cognitive Decline Just Failed a Major Clinical Test (opens in a new tab)

scitechdaily.com · 2026-10-30

Short answerEvidenceSource

Short answer

Mostly supported

Mostly supported.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 3 supported
  • 1 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly supported

Every claim we could check holds up. Three of four claims match the study. This overall rating is based only on the claims we could check. One claim the study doesn't address.

  • 3 supported
  • 1 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4Not coveredIn the larger CREST-2 trial, adding stenting to medication cut strokes by about half compared with medication alone, while surgery did not show the same stroke benefit.View evidenceHide evidence

As statedabout half

Why this verdict

The supplied abstract-level paper profile is for the CREST-H cognitive substudy and does not provide evidence on parent CREST-2 stroke-prevention outcomes, including whether stenting cut strokes by about half or whether surgery lacked the same stroke benefit. This claim may concern related parent-trial results, but it is not verifiable from the supplied abstract profile.

Claim 2 of 4SupportedRestoring blood flow to the brain seemed promising for protecting thinking skills, but opening severely narrowed carotid arteries did not produce the hoped-for cognitive boost.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the central point that carotid revascularization plus intensive medical management did not show a 1-year cognitive benefit over intensive medical management alone in the CREST-H substudy. The story’s wording is somewhat broad, but the claim is hedged and aligns with the paper’s conclusion that revascularization did not improve cognition via restoration of flow in this substudy cohort.

1

Study evidence

In the prespecified subgroup with reduced baseline cognition (z ≤ −1.0 SD; n=51), there was no statistically significant difference in 1-year composite cognitive z score between revascularization+IMM and IMM alone after adjustment (adjusted difference −0.15 SD).-0.15 SD (95% CI, -0.54 to 0.24)

“This substudy was conducted within a multicenter phase 3 randomized clinical trial.”
Claim 3 of 4SupportedA Columbia-led randomized trial found that people with severe carotid artery narrowing had no additional cognitive benefit from stenting or surgery compared with medication alone over one year.View evidenceHide evidence

As statedover one year

Why this verdict

The paper profile reports a randomized comparison of carotid endarterectomy or stenting plus intensive medical management versus medical management alone, with no significant adjusted 1-year cognitive advantage for revascularization in the prespecified reduced-cognition subgroup. The claim is supported as a summary of the trial finding, though the precise paper scope is narrower: high-grade asymptomatic ICA stenosis, complete-data participants, and especially the reduced-baseline-cognition subgroup.

1

Study evidence

In the prespecified subgroup with reduced baseline cognition (z ≤ −1.0 SD; n=51), there was no statistically significant difference in 1-year composite cognitive z score between revascularization+IMM and IMM alone after adjustment (adjusted difference −0.15 SD).-0.15 SD (95% CI, -0.54 to 0.24)

“This substudy was conducted within a multicenter phase 3 randomized clinical trial.”
Claim 4 of 4SupportedThe findings challenge the idea that reopening these arteries can reverse cognitive decline in patients without associated symptoms.View evidenceHide evidence

Why this verdict

The paper’s discussion-level interpretation says the findings suggest revascularization did not improve cognitive dysfunction via restoration of flow in chronic asymptomatic carotid stenosis over 1 year. The story’s hedged framing that the results challenge the idea of reversing cognitive decline in asymptomatic patients is consistent with that interpretation, although the paper measured 1-year composite cognitive z-score change rather than directly proving effects on long-term cognitive decline.

1

Study evidence

In the prespecified subgroup with reduced baseline cognition (z ≤ −1.0 SD; n=51), there was no statistically significant difference in 1-year composite cognitive z score between revascularization+IMM and IMM alone after adjustment (adjusted difference −0.15 SD).-0.15 SD (95% CI, -0.54 to 0.24)

“This substudy was conducted within a multicenter phase 3 randomized clinical trial.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The studied population had high-grade asymptomatic internal carotid artery stenosis, and the primary cognitive analysis emphasized participants with reduced baseline cognition.

    The story mentions severe carotid narrowing and absence of associated symptoms, but it does not clearly reflect the important restriction that the primary analysis was in a small subgroup with reduced baseline cognition.

    From Randomized clinical trial substudy

  • A prespecified primary analysis tested whether baseline cerebral hemodynamic impairment, measured by MR or CT perfusion time-to-peak delay, modified any cognitive effect of revascularization; this interaction was not significant.

    The story discusses restoring blood flow generally, but it does not report the paper’s specific hemodynamic-impairment interaction analysis, which was central to the substudy’s objective.

    From Randomized clinical trial substudy

  • The reduced-cognition subgroup was small, with 51 participants, limiting precision and power for detecting treatment effects or interactions.

    The story caveats do not mention the small prespecified subgroup size, an important interpretation-changing limitation for a null cognitive finding.

    From Randomized clinical trial substudy

  • The analyzed complete-data set excluded participants because of missing baseline imaging, cognitive exams, or covariates: 291 of 392 enrolled participants had complete data.

    The story does not mention missing-data exclusions or that the analysis used a complete-data subset, which affects interpretation of generalizability and precision.

    From Randomized clinical trial substudy

4 things the story did carry across
  • CREST-H was a randomized substudy within CREST-2 comparing carotid revascularization—endarterectomy or stenting—plus intensive medical management with intensive medical management alone.
  • The primary cognitive outcome was 1-year change/difference in a composite cognitive z score based on five cognitive tests.
  • The key result was no statistically significant adjusted 1-year cognitive advantage for revascularization plus intensive medical management over intensive medical management alone; the reported adjusted difference was −0.15 SD with a 95% CI from −0.54 to 0.24.
  • Outcome follow-up in the substudy was limited to 1 year.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

1

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoTest whether carotid revascularization (endarterectomy or stenting) plus intensive medical management (IMM) vs IMM alone improves 1-year cognitive outcomes, and whether any cognitive benefit varies by baseline cerebral hemodynamic impairment, among participants with high-grade asymptomatic ICA stenosis and reduced baseline cognition (CREST-H substudy within CREST-2).Randomized clinical trial substudyExpand

In plain English

Substudy of the CREST-2 randomized trial testing whether carotid revascularization (endarterectomy or stenting) plus intensive medical management (IMM) versus IMM alone improves 1-year composite cognitive z score among participants with high-grade (≥70%) asymptomatic internal carotid artery stenosis and reduced baseline cognition (z ≤ -1.0 SD), and whether any effect varies by baseline cerebral hemodynamic impairment measured as interhemispheric time-to-peak (TTP) delay on MR or CT perfusion.

Key findings

  • In the prespecified subgroup with reduced baseline cognition (z ≤ −1.0 SD; n=51), there was no statistically significant difference in 1-year composite cognitive z score between revascularization+IMM and IMM alone after adjustment (adjusted difference −0.15 SD).-0.15 SD (95% CI, -0.54 to 0.24)
  • The prespecified interaction testing whether baseline cerebral hemodynamic impairment (TTP interhemispheric delay) modified the effect of revascularization on 1-year cognition was not significant.Interaction β = 0.018 (95% CI, -0.025 to 0.061); P = .40
“This substudy was conducted within a multicenter phase 3 randomized clinical trial.”
What this piece can’t prove
  • Primary analyses reported for a subset with complete baseline imaging and cognitive/covariate data (291 of 392 enrolled); 61 excluded for missing baseline imaging and 40 for missing cognitive exams or covariates.
  • The prespecified reduced-cognition subgroup was small (n=51), which may limit precision and power for detecting treatment effects or interactions.
  • Outcome assessment limited to 1-year follow-up as reported in this substudy abstract.
  • Hemodynamic impairment classification relied on interhemispheric TTP delay from MR or CT perfusion as defined in the protocol.
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 15 candidate papers

Candidate

ASYMPTOMATIC CAROTID STENOSIS, WHITE MATTER DISEASE AND COGNITION: CONTRIBUTIONS TO A CLINICAL PROFILE

2018 · Crossref

Source (opens in a new tab)

And 9 more candidates considered.